Bevan, C*
Cited by
Cited by
The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1
CL Bevan, S Hoare, F Claessens, DM Heery, MG Parker
Molecular and cellular biology, 1999
Impact of analytical bias in metabonomic studies of human blood serum and plasma
O Teahan, S Gamble, E Holmes, J Waxman, JK Nicholson, C Bevan, ...
Analytical chemistry 78 (13), 4307-4318, 2006
Prostate cancer cell malignancy via modulation of HIF-1α pathway with isoflurane and propofol alone and in combination
H Huang, LL Benzonana, H Zhao, HR Watts, NJS Perry, C Bevan, ...
British journal of cancer 111 (7), 1338-1349, 2014
The role of androgen receptor mutations in prostate cancer progression
GN Brooke, CL Bevan
Current genomics 10 (1), 18-25, 2009
Circulating microRNAs as potential new biomarkers for prostate cancer
A Sita-Lumsden, DA Dart, J Waxman, CL Bevan
British journal of cancer 108 (10), 1925-1930, 2013
Androgen-regulated processing of the oncomir miR-27a, which targets Prohibitin in prostate cancer
CE Fletcher, DA Dart, A Sita-Lumsden, H Cheng, PS Rennie, CL Bevan
Human molecular genetics 21 (14), 3112-3127, 2012
Hey1, a mediator of notch signaling, is an androgen receptor corepressor
B Belandia, SM Powell, JM García-Pedrero, MM Walker, CL Bevan, ...
Molecular and cellular biology, 2005
Androgens target prohibitin to regulate proliferation of prostate cancer cells
SC Gamble, M Odontiadis, J Waxman, JA Westbrook, MJ Dunn, R Wait, ...
Oncogene 23 (17), 2996-3004, 2004
Visualising androgen receptor activity in male and female mice
DA Dart, J Waxman, EO Aboagye, CL Bevan
PloS one 8 (8), e71694, 2013
Analysis of the steroid receptor coactivator 1 (SRC1)-CREB binding protein interaction interface and its importance for the function of SRC1
HM Sheppard, JC Harries, S Hussain, C Bevan, DM Heery
Molecular and cellular biology, 2001
Role of androgen receptor variants in prostate cancer: report from the 2017 mission androgen receptor variants meeting
J Luo, G Attard, SP Balk, C Bevan, K Burnstein, L Cato, A Cherkasov, ...
European urology 73 (5), 715-723, 2018
Light-triggered enzymatic reactions in nested vesicle reactors
JW Hindley, Y Elani, CM McGilvery, S Ali, CL Bevan, RV Law, O Ces
Nature communications 9 (1), 1093, 2018
Mechanisms of androgen receptor signalling via steroid receptor coactivator-1 in prostate.
SM Powell, V Christiaens, D Voulgaraki, J Waxman, F Claessens, ...
Endocrine-related cancer 11 (1), 117-130, 2004
Single-molecule amplification-free multiplexed detection of circulating microRNA cancer biomarkers from serum
S Cai, T Pataillot-Meakin, A Shibakawa, R Ren, CL Bevan, S Ladame, ...
Nature Communications 12 (1), 3515, 2021
Building a synthetic mechanosensitive signaling pathway in compartmentalized artificial cells
JW Hindley, DG Zheleva, Y Elani, K Charalambous, LMC Barter, PJ Booth, ...
Proceedings of the National Academy of Sciences 116 (34), 16711-16716, 2019
Revising the role of the androgen receptor in breast cancer
FM Fioretti, A Sita-Lumsden, CL Bevan, GN Brooke
Journal of molecular endocrinology 52 (3), R257-R265, 2014
Characterization of the two coactivator-interacting surfaces of the androgen receptor and their relative role in transcriptional control
V Christiaens, CL Bevan, L Callewaert, A Haelens, G Verrijdt, ...
Journal of Biological Chemistry 277 (51), 49230-49237, 2002
Prohibitin, a protein downregulated by androgens, represses androgen receptor activity
SC Gamble, D Chotai, M Odontiadis, DA Dart, GN Brooke, SM Powell, ...
Oncogene 26 (12), 1757-1768, 2007
Mechanisms of androgen receptor activation in advanced prostate cancer: differential co-activator recruitment and gene expression
GN Brooke, MG Parker, CL Bevan
Oncogene 27 (21), 2941-2950, 2008
Mini-review: Foldosome regulation of androgen receptor action in prostate cancer
LQ Cano, DN Lavery, CL Bevan
Molecular and cellular endocrinology 369 (1-2), 52-62, 2013
The system can't perform the operation now. Try again later.
Articles 1–20